Component
Social determinants verification
Confirming a person’s actual circumstances, with their participation, so that the support offered is support that can reach them.
Why this exists
The evidence on social determinants is not a background section. Disability carries an adjusted hazard ratio of 2.80 for fatal opioid overdose, recent incarceration 2.70, unemployment 2.46. A quarter of deaths in a large cohort of people experiencing homelessness were drug overdoses, at roughly twelve times the state adult rate.
Those numbers have an operational meaning that gets missed. They mean that the interventions in this program have preconditions. Delivery needs an address. Monitoring needs a phone that stays charged. Safe storage needs a lockable space in a home the person controls. Follow-up needs transport. A program that enrolls someone in an intervention whose preconditions they do not have has not helped them; it has set them up to fail and then recorded the failure against their name.
So the verification here is not about establishing whether a claim is true. It is about establishing what will actually work.
How it works
- Structured assessment with the patient, covering housing stability, transportation, the ability to store medication securely, who else is in the household, income and benefit status, and social support.
- A site visit where one is agreed, arranged in advance and with the patient present — for the practical purpose of confirming that delivery can reach them and that safe storage is possible, and of identifying what is missing.
- Findings that produce referrals. If the assessment identifies a housing problem, a transport problem or a benefits problem, the output is a referral to whoever handles that in the agency’s jurisdiction. An assessment that only produces a record is extraction.
- Revisited, not fixed. Circumstances change faster in this population than anywhere else in medicine.
What this is not
It is not an unannounced inspection. Visits are arranged with the patient, at a time they agree, and they can decline one without losing access to the program. A visit that happens without consent is not this component.
It is not eligibility verification for a benefit, and findings are not reported to any agency for that purpose. This is a component of clinical care, and confusing it with benefits enforcement would destroy the trust the whole program runs on.
It is not a means test. Nothing here determines whether someone deserves treatment.
It is not an assessment of anyone else in the household. Other people in a home have not consented to anything and are not the subject of this.
It is not a criminal-history check.
Questions this raises
Is the site visit optional?
Yes. It is arranged in advance with the patient, and declining it does not remove anyone from the program or from care. Its purpose is practical — confirming that delivery can reach the person and that medication can be stored safely — and that purpose evaporates if the visit is coercive. See consent that means something.
Are findings reported to benefits or housing enforcement?
No. Findings produce referrals to services the patient may need, not reports to enforcement. A social determinants assessment that fed enforcement would be worthless within a month, because nobody would answer honestly. See data governance and our note on why trust is load-bearing.
Sources
Every figure on this page is traceable to the source listed here.
- Altekruse SF, Cosgrove CM, Altekruse WC, Jenkins RA, Blanco C. Socioeconomic risk factors for fatal opioid overdoses in the United States: findings from the Mortality Disparities in American Communities Study (MDAC). PLoS One. 2020;15(1):e0227966. PMID 31951640. View source.
- Fine DR, Dickins KA, Adams LD, et al. Drug overdose mortality among people experiencing homelessness, 2003 to 2018. JAMA Netw Open. 2022;5(1):e2142676. PMID 34994792. View source.
- National Academies of Sciences, Engineering, and Medicine. Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use. Bonnie RJ, Ford MA, Phillips JK, editors. Washington, DC: The National Academies Press; 2017. View source.